Haemonetics | HAE - Ordinary Share Capital


Haemonetics reported $45.47M in Ordinary Share Capital for its fiscal quarter ending in June of 2026.





Ordinary Share Capital Change Date
Baxter International USD 517M 549K Jun/2026
Becton, Dickinson and Co. USD 370.59M 95.05M Jun/2026
Boston Scientific USD 1.48B 2.66M Dec/2025
Cooper Companies USD 195.11M 14K Mar/2026
Fresenius EUR 563.24M 0 Jun/2026
Fresenius Medical Care EUR 266.11M 3.98M Jun/2026
Globus Medical USD 135.67M 611K Mar/2026
Haemonetics USD 45.47M 1.36M Jun/2026
ICU Medical USD 24.99M 305K Mar/2026
Intuitive Surgical USD 354.16M 1.01M Jun/2026
Medtronic USD 1.28B 3.19M Mar/2026
Merit Medical Systems USD 59.71M 55K Jun/2026
Neogen USD 217.7M 27K Mar/2026
OraSure Technologies USD 70.39M 1.87M Dec/2025
Plus Therapeutics USD 275K 138.4M Mar/2026
Quidel USD 68.1M 200K Mar/2026
ResMed USD 145.06M 45.78M Jun/2026
STAAR Surgical USD 50.12M 343K Jun/2026
Steris USD 98.07M 72K Mar/2026
Stryker USD 383.4M 416K Jun/2026
Teleflex USD 44.26M 70K Mar/2026
Terumo JPY 1.48B 19K Jun/2026
Thermo Fisher Scientific USD 371.62M 1000 Jun/2026
US Physical Therapy USD 15.23M 107.81K Mar/2026
Zimmer Biomet Holdings USD 193.4M 2.1M Jun/2026